{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"65.8","upperLimit":"84.7","value":"75.3"},{"groupId":"OG001","lowerLimit":"62.4","upperLimit":"81.8","value":"72.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"83"},{"groupId":"OG001","value":"90"}],"units":"Participants"}],"title":"Female"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"59.0","upperLimit":"72.7","value":"65.9"},{"groupId":"OG001","lowerLimit":"72.6","upperLimit":"84.4","value":"78.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"204"},{"groupId":"OG001","value":"200"}],"units":"Participants"}],"title":"Male"}],"denoms":[{"counts":[{"groupId":"OG000","value":"287"},{"groupId":"OG001","value":"290"}],"units":"Participants"}],"description":"Overall survival time is defined as time from registration/randomization to the date of death from any cause or last known follow-up (censored). Overall survival rates are estimated by the Kaplan-Meier method. Analysis occurred after all participants had potentially been on study for at least 5 years. The distributions of survival times are compared, which is reported in the statistical analysis results. Five-year rates are provided.","dispersionType":"95% Confidence Interval","groups":[{"description":"Radiation therapy: 60 Gy intensity-modulated radiotherapy (IMRT), 2 Gy/day in 30 fractions (5 days a week for 6 weeks).","id":"OG000","title":"IMRT"},{"description":"Radiation therapy (RT): 60 Gy IMRT, 2 Gy/day in 30 fractions (5 days a week for 6 weeks).\n\nCetuximab: 400 mg/m\\^2 intravenously (IV) at least 5 days prior to IMRT; 250 mg/m\\^2 IV once a week for 6 weeks during RT and continuing 4 weeks after RT.","id":"OG001","title":"IMRT Plus Cetuximab"}],"paramType":"NUMBER","populationDescription":"Randomized eligible participants. Data were stratified by sex.","reportingStatus":"POSTED","timeFrame":"From randomization to date of death or last follow-up. Maximum follow-up at time of analysis was 12.1 years.","title":"Percentage of Participants Alive (Overall Survival) by Sex","type":"OTHER_PRE_SPECIFIED","unitOfMeasure":"percentage of participants"}